Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07139418 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy

StatusRecruiting
PhaseNot specified
SponsorJichao Qin
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 6 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 30, 2025 to Oct 7, 2025
    • Study description expanded, about 24 words
    • Collaborator revised
    • Publications: details revised at 4 of 4 entries
    • Study title expanded, about 6 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Jichao Qin
7 trials monitored
See 1 trial at risk
Gastric Cancer
1,278 trials monitored
See 63 trials at risk
This study aims to examine the predictive value of metastatic gastric mesenteries, which contains metastatic lymph node, in 6 gastric mesenteries; and importantly, to further evaluate the relationship between the number of metastatic gastric mesenteries and prognosis in the gastric cancer patients who received D2+complete mesogastric excision (CME).
Trial Details
NCT Number NCT07139418
Lead Sponsor Jichao Qin
Collaborators: Zhejiang University
Conditions
(from sponsor)		 Gastric Carcinoma
Related terms Lymphatic Metastasis, Stomach Neoplasms
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov